scholarly journals Recent trends in breast, cervical and colorectal cancer screening test utilization in Canada, using self-reported data from 2008 and 2012

2015 ◽  
Vol 22 (4) ◽  
pp. 297 ◽  
Author(s):  
D. Major ◽  
D. Armstrong ◽  
H. Bryant ◽  
W. Cheung ◽  
K. Decker ◽  
...  

In Canada, self-reported data from the Canadian Community Health Survey 2008 and 2012 provide an opportunity to examine overall utilization of breast, cervical, and colorectal cancer screening tests for both programmatic and opportunistic screening.Among women 50–74 years of age, utilization of screening mammography was stable (62.0% in 2008 and 63.0% in 2012). Pap test utilization for women 25–69 years of age remained high and stable across Canada in 2008 and 2012 (78.9% in 2012). The percentage of individuals 50–74 years of age who reporting having at least 1 fecal test within the preceding 2 years increased in 2012 (to 23.0% from 16.9% in 2008), but remains low.Stable rates of screening mammography utilization (about 30%) were reported in 2008 and 2012 among women 40–49 years of age, a group for which population-based screening is not recommended. Although declining over time, cervical cancer screening rates were high for women less than 25 years of age (for whom screening is not recommended). Interestingly, an increased percentage of women 70–74 years of age reported having a Pap test.In 2012, a smaller percentage of women 50–69 years of age reported having no screening test (5.9% vs. 8.5% in 2008), and more women reported having the three types of cancer screening tests (19.0% vs. 13.2%).Efforts to encourage use of screening within the recommended average-risk age groups are needed, and education for stakeholders about the possible harms of screening outside those age groups has to continue.

Author(s):  
Esra Sancaktar ◽  
Özge Tuncer

INTRODUCTION: In this study, ıt was aimed to determine the level of awareness by evaluating the knowledge, attitudes and behaviors of people about the risk factors, symptoms and early diagnosis methods of colorectal cancer. METHODS: The study was conducted with a face-to-face interview with 300 patients who met the inclusion criteria of the study, who applied to the Family Medicine Clinic of İzmir Bozyaka Education and Research Hospital at the University of Health Sciences, between January 2019 and February 2019. Data obtained statistically were analyzed using SPSS (Statistical Package for Social Sciences) program. RESULTS: The mean age of the participants was 51,8±8,66 years and the age ranged was between 40 to 70 years. 68.3% (205) of the participants were female. When the educational status of the patients is examined, the highest rate is composed of primary school graduates with 33% (99), followed by university graduates with 28.7% (86). 66.3% (124) of those who have heard about colorectal cancer screening test reported that they heard it from health care workers, 25.7%(48) from their relatives and friends. 62.3% (187) of the participants heard about colorectal cancer screening tests. While 96.7% (290) of the participants believed that those tests were necessary, 85% (255) of the participants thought that the aim of the colorectal cancer screening test was to catch the disease at an early stage. Only 29% (87) of the participants were informed by the doctor about colorectal cancer screening tests. Only 25% (75) of the participants knew names of colorectal cancer screening tests correctly. 39.7% (60) of the participants over the age of 50 had a CRC screening test. While the participants considered changes in the habit of defecation as the most frequent sign of CRC, the most known risk factor was the family history of CRC. DISCUSSION AND CONCLUSION: In our study ıt was determined that individuals had a lock of knowledge about CRC and the rate of screening test recommended for those over the age of 50 was low. For this reason, Family Physicians, who are great importance in terms of ptotective medicine should inform and guide their patients more about the screening test.


Cancer ◽  
2011 ◽  
Vol 118 (10) ◽  
pp. 2726-2734 ◽  
Author(s):  
Sarah T. Hawley ◽  
Amy McQueen ◽  
L. Kay Bartholomew ◽  
Anthony J. Greisinger ◽  
Sharon P. Coan ◽  
...  

2019 ◽  
Vol 2 (3) ◽  
pp. e191156 ◽  
Author(s):  
Shivan J. Mehta ◽  
Rebecca S. Pepe ◽  
Nicole B. Gabler ◽  
Mounika Kanneganti ◽  
Catherine Reitz ◽  
...  

2018 ◽  
Vol 15 ◽  
Author(s):  
Djenaba A. Joseph ◽  
Jessica B. King ◽  
Thomas B. Richards ◽  
Cheryll C. Thomas ◽  
Lisa C. Richardson

2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 411-411
Author(s):  
Jérôme Viguier ◽  
Jean F. Morere ◽  
Xavier B. Pivot ◽  
Yvan Coscas ◽  
Jean-Yves Blay ◽  
...  

411 Background: In France, after a pilot population-based screening program (2002-2003), a national organized program targeting 17 million persons was progressively implemented starting in 2005 and generalized after 2009. The EDIFICE 3 survey was conducted in 2011, after EDIFICE 1 (2005) and EDIFICE 2 (2008), to provide a better understanding of the participation of the French population in the colorectal cancer screening program and to assess the evolution between the three periods. Methods: This third nationwide observational study, EDIFICE 3, was conducted through phone interviews among a representative sample of 1603 subjects aged between 40 and 75years, using the quota method. This analysis focused on the target population of the national screening program (50-74 years old). Results: In 2011, 59% of subjects between 50 and 74 years (N=946) declared having performed a screening test for colorectal cancer (including fecal test or colonoscopy) versus 38% in 2008 (p<0.05) and 25% in 2005 (p<0.05). Colorectal cancer screening increased significantly in all age groups, especially between 65 and 69 years, and for both sexes. Among the screened population, the recommended interval between two tests was respected in 51% of cases in EDIFICE 3. 62% of unscreened individuals plan to undergo a screening test in the near future. The main factors increasing the probability of screening were: being encouraged by one’s family, the existence of a case colorectal cancer in the family circle, higher frequency of medical consultation, better knowledge of the screening process and being reassured by the screening. The main reasons for not undergoing the screening were: not feeling concerned, fear of exams or results, no recommendation by the GP and carelessness. Conclusions: The European guideline objective rate of participation for colorectal cancer screening (65%) is not yet reached. This goal could be achieved by motivating the unscreened population already planning to perform a test. The trend for increasing testing will probably be confirmed in the future if the reasons for non-attendance in an organized program are addressed.


2013 ◽  
Vol 10 (4) ◽  
pp. 489-499 ◽  
Author(s):  
Alex Ghanouni ◽  
Samuel G Smith ◽  
Steve Halligan ◽  
Andrew Plumb ◽  
Darren Boone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document